Introduction - Uppsala Monitoring Centre

Med 2008;101: 148–155.
Louis PCA. Recherche sur les effets de la saignée dans plusieurs maladies inflammatoires. Archives générales de Médecine
1828; 18: 321–336.
Louis-Courvoisier M. An 18th century controlled trial prompted by a potential shortage of hospital beds. J R Soc Med 2007;
100(10): 481-482; doi: 10.1258/jrsm.100.10.481.
Lucey HC. The therapeutic and reaction effects of Kharsivan. BMJ 1916; 1: 614–616.
Luft D, Schmülling RM and Eggstein M. Lactic acidosis in biguanide-treated diabetics: a review of 330 cases. Diabetologia
1978;14: 75–87.
Lunde PKM. Drug and product selection - an essential part of the therapeutic benefit/risk ratio strategy? In: Soda T Ed. Drug-
Induced Sufferings: Excerpta Medica, 1980: 129–136.
MacCallum RI. Antimony in medical history: an account of the medical uses of antimony and its compounds since early times
to the present. Pentland Press Edinburgh 1999.
MacGregor AB. The search for a chemical cure for cancer. Med Hist 1966 October; 10(4): 374-385.
Madison FW and Squier TL. The etiology of primary granulocytopenia (agranulocytic angina) JAMA 1934; 102: 755–9.
Maeder T. Adverse Reactions. New York: William Morrow 1994.
Maehle A-H. Opium: explanations of an ambiguous drug in drugs on trial: experiential pharmacology and therapeutic
innovation in the eighteenth century. Clio Medica 1999; 53, Rodopi.
Magendie F. Lectures on blood. Philadelphia. Haswell, Barrington and Haswell, 1839.
MacMahon B. More on Bendectin. JAMA 1981; 246: 371–2.
Making Medicines – A brief history of Pharmacy and Pharmaceuticals. Ed. Stuart Anderson. Pharmaceutical Press. 2005.
Malon De M. Preserver of the blood: or bleeding demonstrated to be always pernicious, and often mortal. London: Wilson &
Nicol, 1774.
Malt RA, Olken HG and Goade WJ. Renal tubular necrosis after oral cholecystography. Arch Surg 1963; 87: 743.
Manigand G. Accidents neurologiques des médicaments. Thérapie 1982; 37: 113-141.
Mann R. Modern Drug Use. An enquiry on historical principles, MTP Press Ltd. 1984.
Maoshing Ni (translator) The essential text of Chinese health and healing. The Yellow Emperors Classic of Medicine. Shambala
Publications, Boston.
Mapother ED. Piperazine and other eliminents in the treatment and prevention of gout. Practitioner October 1894.
Marson P and Pasero G. Il contibuto Italiano alla storia dei salicilati. Reumatismo 2006; 58(1): 66–75.
Marten J. A treatise of the Venereal Disease. 7th edition, 1711.
Martinet L. A manual of pathology containing the symptoms, diagnosis and morbid characters of diseases, together with an
exposition of the different methods of examination applicable to the affections of the head, chest and abdomen. Translated
with notes and Additions by Jones Quain. 2nd ed. London: W Simpkin and R Marshall, 1827.
Martinez-L J, Letona L, Barbolla L, Frieyro E, Bouza E, Gilsanz F and Fernández MN. Immune haemolytic anaemia and renal
failure induced by streptomycin. Br J Haematol 1977; 35: 561.
Masheter HC. The Debendox saga. BMJ 1985; 291: 1580.
Mathias A. Mercurial disease: an inquiry into the history and nature of the disease produced in the human. London: Becket &
Ponder, 1810.
Mattioli PA. Dioscorides. De materia medica. Translated by Pietro Andrea Mattioli. Venice: Bascarini, 1544; 443 pp.
Mauer EF. The Toxic Effects of Phenylbutazone(Butazolidin), review of the literature and report of the twenty-third death
following its use. New Engl J Med 1955; 253(10): 404–410.
Mayanagi M. Pharmacotherapy and Chinese hygienic concepts as seen in the Xiao Pin Fang of medieval China. Proceedings
of the 12 th International Symposium on the Comparative History of Medicine. 1987 Susono-shi, Shizuoka, Japan.
Maywood Robert. An essay, on the operation of mercury, in the human body; in which, the manner how salivation is
produced, by that medicine, is attempted to be explained: interspersed with observations on the treatment of the venereal
disease. By Robert Maywood, ... London, 1787. Based on information from English Short Title Catalogue. Eighteenth Century
Collections Online. Gale Group.
http://0-galenet.galegroup.com.libsys.wellcome.ac.uk/servlet/ECCO
McCarthy DD and Chalmers TM. Hematological complications of phenylbutazone therapy: review of the literature and report
of two cases Canad Med Ass J 1964; 90; 1061–1067.
McConaghey RMS. The dawn of state medicine in Britain. Pro Roy Soc Med. 1967; 60: 483–487.
McCredie J. Chapter 2 in ‘Beyond Thalidomide. Birth defects explained’. RSM Press. 2008.
McDermott W. Toxicity of streptomycin. Am J Med 1947; 2: 491–500.
McEwen J. Adverse reactions–a personal view of their history. Int J Pharm Med 1999; 13: 269–277.